Lisata Therapeutics, Inc.
LSTA
$5.03
-$0.01-0.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.95M | -4.25M | -4.66M | -4.72M | -4.61M |
| Total Depreciation and Amortization | 15.00K | 44.00K | 44.00K | 43.00K | 41.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 852.00K | 218.00K | 219.00K | 489.00K | 556.00K |
| Change in Net Operating Assets | -1.16M | 645.00K | 440.00K | -1.21M | -515.00K |
| Cash from Operations | -3.25M | -3.34M | -3.96M | -5.40M | -4.53M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -28.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 5.15M | 505.00K | 9.46M | 1.39M |
| Cash from Investing | 0.00 | 5.15M | 505.00K | 9.43M | 1.39M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 205.00K | 353.00K | 74.00K | 220.00K | 36.00K |
| Repurchase of Common Stock | 0.00 | 0.00 | -10.00K | -243.00K | -132.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 205.00K | 353.00K | 64.00K | -23.00K | -96.00K |
| Foreign Exchange rate Adjustments | 2.00K | 2.00K | 5.00K | 2.00K | -65.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.04M | 2.16M | -3.38M | 4.01M | -3.30M |